$ENTB has completed pre-clinical research indicati
Post# of 94115
![Avatar](/images/ProfileImages/347566354_1498_zz.png)
They have licensed this associated technology out to Zander Therapeutics, primarily for use by that company’s wholly owned subsidiary, Entest BioMedical Inc, a publicly traded biotechnology company focused on veterinary medicine. Learn more at: http://zandertherapeutics.weebly.com
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)